atovaquone (Mepron)

From Aaushi
Jump to navigation Jump to search

Introduction

Tradename: Mepron.

Indications

Dosage

750 mg PO BID[1], TID[2] for 21 days

Suspension: 750 mg/5 mL (210 mL).

Pharmacokinetics

elimination via liver

Adverse effects

Drug interactions

Laboratory

More general terms

Component of

References

  1. 1.0 1.1 The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
  2. 2.0 2.1 Kaiser Permanente Northern California Regional Drug Formulary, 1998
  3. Medical Knowledge Self Assessment Program (MKSAP) 11, American College of Physicians, Philadelphia 1998
  4. Prescriber's Letter 7(8):48 2000
  5. Department of Veterans Affairs, VA National Formulary
  6. Deprecated Reference

Database